In recent years, several studies have reported that the level of serum tumor biomarkers is closely related to the diagnosis and treatment of lung cancer and can be used for assessing the effectiveness of chemotherapy or radiotherapy.26, 27, 28 We simultaneously detected and conducted comparative analysis of the tumor markers CEA, CYFRA21‐1, and NSE. The gene discussed is CEACAM5; the disease is neoplasm.